Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled study of intravesical KRP-116D (dimethyl sulfoxide) in Japanese patients with interstitial cystitis
jRCT2080223511Phase 3Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Dimethyl sulfoxide in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) (2 arms), sponsored by Kyorin Pharmaceutical. Started Apr 2017; status: completed.
02
Drugs
Dimethyl sulfoxide
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on jRCT2080223511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223511.